Topical immunotherapy: unapproved uses, dosages, or indications

Clin Dermatol. 2002 Sep-Oct;20(5):515-21. doi: 10.1016/s0738-081x(02)00272-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Topical
  • Adult
  • Alopecia Areata / diagnosis
  • Alopecia Areata / drug therapy*
  • Child
  • Controlled Clinical Trials as Topic
  • Cyclopropanes / administration & dosage*
  • Cyclopropanes / adverse effects
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / adverse effects
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Approval*
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects
  • Immunotherapy / methods*
  • Male
  • Middle Aged
  • Prognosis
  • Risk Assessment
  • Treatment Outcome
  • United Kingdom
  • Warts / diagnosis
  • Warts / drug therapy*

Substances

  • Cyclopropanes
  • Dermatologic Agents
  • Immunosuppressive Agents
  • diphenylcyclopropenone